Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Science Translational Medicine|July 5, 2013
TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transferMagdalena Nauerth, Bianca Weißbrich, Robert Knall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Science Signaling|August 25, 2021
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo functionAlexander I Salter, Anusha Rajan, Jacob J Kennedy, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Blood|September 20, 2017
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapyKevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, et al.
Blood Advances|November 20, 2019
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapyJoshua A Hill, Elizabeth M Krantz, Kevin A Hay, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Science Translational Medicine|July 5, 2013
TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transferMagdalena Nauerth, Bianca Weißbrich, Robert Knall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Science Signaling|August 25, 2021
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo functionAlexander I Salter, Anusha Rajan, Jacob J Kennedy, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Blood|September 20, 2017
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapyKevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, et al.
Blood Advances|November 20, 2019
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapyJoshua A Hill, Elizabeth M Krantz, Kevin A Hay, et al.
Pageof 18